<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Korean Med Sci</journal-id>
      <journal-id journal-id-type="publisher-id">JKMS</journal-id>
      <journal-title-group>
        <journal-title>Journal of Korean Medical Science</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1011-8934</issn>
      <issn pub-type="epub">1598-6357</issn>
      <publisher>
        <publisher-name>The Korean Academy of Medical Sciences</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">15483360</article-id>
      <article-id pub-id-type="pmc">2816347</article-id>
      <article-id pub-id-type="doi">10.3346/jkms.2004.19.5.763</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Malignant Gastrointestinal Stromal Tumor of the Gallbladder</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Park</surname>
            <given-names>Jong Kyung</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Choi</surname>
            <given-names>Seung Hye</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Seong</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Min</surname>
            <given-names>Ki Ouk</given-names>
          </name>
          <xref ref-type="aff" rid="A2">*</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Yun</surname>
            <given-names>Sang Seob</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jeon</surname>
            <given-names>Hae Myung</given-names>
          </name>
          <xref ref-type="aff" rid="A3">&#x2020;</xref>
        </contrib>
      </contrib-group>
      <aff id="A1">Department of Surgery, St. Paul's Hospital, The Catholic University of Korea School of Medicine, Seoul, Korea.</aff>
      <aff id="A2"><label>*</label>Department of Clinical Pathology, St. Paul's Hospital, The Catholic University of Korea School of Medicine, Seoul, Korea.</aff>
      <aff id="A3"><label>&#x2020;</label>Department of Surgery, St. Mary's Hospital, The Catholic University of Korea School of Medicine, Seoul, Korea.</aff>
      <author-notes>
        <corresp>Address for correspondence: Sang Seob Yun, M.D. Department of Surgery, St. Paul's Hospital, The Catholic University School of Medicine, 620-56 Jeonnong-dong, Dongdaemun-gu, Seoul 130-709, Korea. Tel: +82.2-958-2114, Fax: +82.2-958-2136, <email>ssyun@catholic.ac.kr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>10</month>
        <year>2004</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>30</day>
        <month>10</month>
        <year>2004</year>
      </pub-date>
      <volume>19</volume>
      <issue>5</issue>
      <fpage>763</fpage>
      <lpage>767</lpage>
      <history>
        <date date-type="received">
          <day>01</day>
          <month>9</month>
          <year>2003</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>10</month>
          <year>2003</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2004 The Korean Academy of Medical Sciences</copyright-statement>
        <copyright-year>2004</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">http://creativecommons.org/licenses/by-nc/3.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Gastrointestinal stromal tumors (GISTs) of the gallbladder are representative of an extremely rare group of tumors. We have encountered a patient with a malignant GIST of the gallbladder and presented it with a review of some articles. A 72-yr-old woman initially presented with right upper quadrant abdominal pain, fever and chills. Emergency cholecystectomy was performed under the impression of gallbladder empyema. Liver metastasis was found at 7 months postoperatively and the patient expired 9 months after the surgery. At the time of cholecystectomy, the gallbladder showed a necrotic serosal surface with an irregular thickened wall. A mass, 6 cm in length and 3 cm in width, encircled the whole wall of the neck and upper body of the gallbladder. Microscopic findings revealed frequent mitotic figures (more than 20/50 HPF) and tumor necrosis. Hyperchromatic, pleomorphic and spindle shaped neoplastic cells that were arranged in a pattern of short fascicles infiltrated the entire layer of the gallbladder. The tumor cells were immunoreactive for CD117 antigen (c-kit protein) and vimentin. They were negative for desmin, smooth muscle actin and S-100 protein. Mutations of the <italic>c-kit</italic> proto-oncogene were not found in this case. These findings were sufficient to provide enough clinical, histopathological and immunohistochemicalevidence in diagnosing our case as a malignant GIST.</p>
      </abstract>
      <kwd-group>
        <kwd>Gastrointestinal Stromal Tumors</kwd>
        <kwd>Antigen, cd117</kwd>
        <kwd>Proto-Oncogene Protein c-kit</kwd>
        <kwd>Gallbladder Neoplasms</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal (GI) tract and may arise anywhere in the tubular GI tract from the esophagus to the rectum. In terms of a more detailed distribution, 50-60% of the lesions arise in the stomach, 20-30% in the small bowel, 10% in the large bowel and 5% in the esophagus (<xref ref-type="bibr" rid="B1">1</xref>). In addition, it has been reported in recent years that identical lesions also occur in the mesentery, omentum and retroperitoneum (<xref ref-type="bibr" rid="B2">2</xref>). The demonstration of KIT expression in these lesions has helped to validate their existence, particularly in exceptional sites such as the gallbladder (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>) or urinary bladder (<xref ref-type="bibr" rid="B5">5</xref>). Recent studies found that GISTs are tumors originating from the interstitial cells of Cajal (ICCs) or primitive stem cells related to ICCs (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). The morphologic appearance of stromal tumors in the gallbladder is identical to that of stromal tumors in the gastrointestinal tract, and ICCs are normally distributed in the gallbladder wall (<xref ref-type="bibr" rid="B8">8</xref>).</p>
      <p>The prognosis of GISTs is difficult to predict due to various clinical patterns and morphologic characteristics and is poor when malignant changes are present or when metastasis occurs to the liver or peritoneal cavity in the early stage (<xref ref-type="bibr" rid="B9">9</xref>). Although GISTs of the gallbladder are extremely rare, we encountered a case of malignant GIST of the gallbladder that showed no mutation of <italic>c-kit</italic> proto-oncogene but had CD117 antigen expression. Thus, we report this case with the literature review.</p>
    </sec>
    <sec sec-type="cases">
      <title>CASE REPORT</title>
      <p>A 72-yr-old woman visited St. Paul's Hospital of the Catholic University of Korea due to symptoms of fever, chills, and intermittent abdominal pain in the right upper quadrant that was present for 10 days and which worsened severe on the day of the visit. Ultrasound examination revealed a significantly dilated gallbladder and wall thickening. Several high echogenic foci with low echoic debris were present in the dependent portion of the gallbladder (<xref ref-type="fig" rid="F1">Fig. 1</xref>). Accordingly, emergency cholecystectomy was performed under the diagnosis of gallbladder empyema.</p>
      <p>Grossly, the gallbladder was dilated and measured 11 cm in length and 5 cm in width. A necrotic serosal surface that was purplish brown in color was observed. Upon opening, the gallbladder wall was thickened and yellowish necrotic tissue was present. A 6 cm long, 3 cm wide mass covered the entire wall of the gallbladder neck and body. Hemorrhage and necrosis were present in the remainder of the mucosal layer.</p>
      <p>Microscopically, tumor cells were present in the entire layer of the gallbladder, and the mucosal layer was flattened due to tumor cells infiltration (<xref ref-type="fig" rid="F2">Fig. 2A</xref>). Most of the tumor cells that were of spindle shape nature with some showing a round to oval appearance arranged in a short fascicle pattern (<xref ref-type="fig" rid="F2">Fig. 2B</xref>). Hyperchromatic nuclei and severe pleomorphism were present in these cells. There was increased mitotic activity with mitotic counts being higher than 20/50 HPF (<xref ref-type="fig" rid="F2">Fig. 2C</xref>), and partially tumor necrosis was also observed. Immunohistochemically, these tumor cells were stained diffusely with moderate intensity for CD117 (dilution 1:50, sc-168, Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.) in the cytoplasm (<xref ref-type="fig" rid="F2">Fig. 2D</xref>) and they were positive for vimentin (dilution 1:25, V9, Signet Laboratories Inc., Dedham, MA, U.S.A.). However, they were negative for CD34 (dilution 1:50, N1632, DAKO, Carpinteria, CA, U.S.A.), desmin (dilution 1:40, ZC-18, ZYMED, San Francisco, CA, U.S.A.), smooth muscle actin (dilution 1:100, 1A4, NeoMarkers, Fremont, CA, U.S.A.) and S-100 protein (dilution 1:50, 4C4.9, NeoMarkers).</p>
      <p>In order to determine the presence of <italic>c-kit</italic> gene mutation, sample sections were deparaffinized and DNA was extracted using the QIAamp DNA Mini Kit (QIAGEN Inc., Valencia, CA, U.S.A.) according to the proteinase K digestion methods. Polymerase chain reaction (PCR) was performed using the primers for 4 regions of the <italic>c-kit</italic> gene, i.e., exons 9, 11, 13, and 17. After the QIAquick PCR purification method (QIAGEN Inc.), the DNA sequence was analyzed using ABI 3700 sequencer (Applied Biosystems, Foster City, CA, U.S.A.) with the PCR products. DNA sequencing performed to determine the presence of the <italic>c-kit</italic> gene mutation revealed no mutation in exons 9, 11, 13, and 17.</p>
      <p>Liver metastasis was found in abdominal CT (<xref ref-type="fig" rid="F3">Fig. 3</xref>) at 7 months postoperatively and the patient expired 9 months after the surgical treatment.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Malignant stromal tumors of the gallbladder are extremely rare. Although some cases of leiomyosarcoma, botryoid rhabdomyosarcoma, angiosarcoma, and Kaposi sarcoma have been occasionally described (<xref ref-type="bibr" rid="B10">10</xref>), only two benign and malignant stromal tumors of the gallbladder with ICCs phenotype have been reported (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>).</p>
      <p>The gallbladder tumor in our case was a high risk GIST as classified according to the risk of aggressive behavior of GIST proposed by Fletcher et al. in the NIH consensus symposium of GIST in 2001 (<xref ref-type="bibr" rid="B11">11</xref>). It has been expressed that the classification of GISTs into benign and malignant categories should be replaced by one that categorizes it into low-risk and high-risk tumors depending on their estimated potential for recurrence and metastasis (<xref ref-type="bibr" rid="B12">12</xref>). This proposal was made because lesions that are very small (less than 2 cm) and possess very low mitotic rates (less than 5/50 HPF) occasionally metastasize. With prolonged follow-up, it appears that almost all GISTs presenting with clinical symptoms or signs which lead to treatment have the potential to behave in a malignant fashion (<xref ref-type="bibr" rid="B11">11</xref>). The tumor in this report was 6 cm in length and 3 cm in width and had mitotic counts of more than 20 mitoses/50 HPF. It consisted of spindle cells most of which had hyperchromatic nuclei, along with significant pleomorphism and tumor necrosis. Actin, desmin and S-100 protein expression were absent but CD117 and vimentin expression were present. CD117 antibody is used to detect the KIT receptor protein and stain ICCs.</p>
      <p>GISTs have been proposed to originate from ICCs because of the expression of KIT protein (<xref ref-type="bibr" rid="B7">7</xref>). KIT protein is also known to be expressed in several cell types, such as hematopoietic stem cells, mast cells, melanocytic cells, and germ cells and is considered to play an important role in the development and maintenance of these cellular elements (<xref ref-type="bibr" rid="B6">6</xref>). ICCs can easily be identified by immunohistochemical staining since they only express CD117, CD34 and vimentin in the gut (<xref ref-type="bibr" rid="B7">7</xref>). ICCs are pacemaker cells forming the nerve network that controls peristaltic movements of the GI tract and are located in the myenteric plexus and dispersed between the smooth muscle cells. It has been reported that the expression of activated KIT protein plays a crucial role in the differentiation and proliferation of ICCs (<xref ref-type="bibr" rid="B13">13</xref>).</p>
      <p>KIT protein is a 145 kDa transmembrane receptor for a growth factor termed stem cell factor and it has an internal tyrosine kinase component (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B14">14</xref>). The extracellular portion of KIT receptor binds to a ligand known as stem cell factor, and the intracellular portion contains the actual kinase enzymatic domain (<xref ref-type="bibr" rid="B15">15</xref>). KIT activation normally occurs when two adjacent receptors are brought together through binding to ligand dimers (<xref ref-type="bibr" rid="B15">15</xref>). However, the oncogenic activation of KIT protein, which is evoked by the oncogenic mutation of the <italic>c-kit</italic> gene itself, does not depend on binding of the KIT ligand, but instead plays a pivotal event in GIST tumorigenesis by inducing the phosphorylation of other proteins during the cell-signaling cascades (<xref ref-type="bibr" rid="B16">16</xref>). Therefore KIT expression might be one of the earliest transforming events in GISTs (<xref ref-type="bibr" rid="B17">17</xref>).</p>
      <p>Many parameters such as tumor size, mitotic rate, mucosal invasion, tumor necrosis, high cellularity, anatomic site, and age have been proposed in predicting the prognosis of GISTs. However, the morphologic features that have gained greatest acceptance as being positive predictors of outcome are tumor size and mitotic rate (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>). According to recent reports, <italic>c-kit</italic> mutation results in an increase in both tumor size and mitotic rate leading to a clinically unfavorable prognosis (<xref ref-type="bibr" rid="B1">1</xref>). Lasota et al. (<xref ref-type="bibr" rid="B2">2</xref>) and Taniguchi et al. (<xref ref-type="bibr" rid="B18">18</xref>) suggested that mutation-positive GISTs showed a higher recurrence rate and death rate than mutation-negative GISTs and that the <italic>c-kit</italic> mutation was a strong candidate marker for predicting prognosis. On the contrary, Sakurai et al. (<xref ref-type="bibr" rid="B19">19</xref>) stated that the relationship between <italic>c-kit</italic> mutation and a poor prognosis of GISTs could not be confirmed. Similarly, although Wardelmann et al. (<xref ref-type="bibr" rid="B20">20</xref>) reported that there was correlation between the <italic>c-kit</italic> mutation and increased mitoses, but there was no statistical significance of the mutation as a prognostic factor. Even though identification of the specific <italic>c-kit</italic> mutation might be important in predicting clinical outcome and response to the KIT-specific therapy (<xref ref-type="bibr" rid="B14">14</xref>), data on the prognostic value of <italic>c-kit</italic> mutations are currently somewhat contradictory (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>) and their therapeutic significance still remains under investigation.</p>
      <p><italic>C-kit</italic> activating mutation was originally reported to be located in the juxtamembrane (exon 11) domain of the gene (<xref ref-type="bibr" rid="B17">17</xref>). However, subsequent studies revealed that mutation was in the extracellular (exon 9) and intracellular tyrosine kinase (exon 13 and 17) domains (<xref ref-type="bibr" rid="B16">16</xref>). In the case of GISTs, mutation usually occurs at exon 11, but when it does not occur at exon 11, rare mutations occur at exon 9 and exon 13 (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B16">16</xref>). The frequency of <italic>c-kit</italic> mutation varies widely from 15% to 71% (<xref ref-type="bibr" rid="B18">18</xref>), at an average between 50-60% (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>). However, we found no mutation in our case.</p>
      <p>Diagnosis of the GIST of the gallbladder is not surprising because the gallbladder is a part of the tubular GI tract, having a common embryologic derivation. It has recently been shown that neoplasms phenotypically identical to gastrointestinal tumors occur as primary tumors in extragastrointestinal locations, principally in the omentum and mesentery (<xref ref-type="bibr" rid="B21">21</xref>). Our case of malignant GIST of the gallbladder, which express KIT protein while lacks the <italic>c-kit</italic> mutation, is histopathologically high risk as well as clinically malignant in nature due to the presence of liver metastases.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Emory</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Sobin</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>Lukes</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>O'Leary</surname>
              <given-names>TJ</given-names>
            </name>
          </person-group>
          <article-title>Prognosis of gastrointestinal smooth muscle (stromal) tumors: dependence on anatomic site</article-title>
          <source>Am J Surg Pathol</source>
          <year>1999</year>
          <volume>23</volume>
          <fpage>82</fpage>
          <lpage>87</lpage>
          <pub-id pub-id-type="pmid">9888707</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lasota</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Jasinski</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sarlomo-Rikala</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Miettinen</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas</article-title>
          <source>Am J Pathol</source>
          <year>1999</year>
          <volume>154</volume>
          <fpage>53</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="pmid">9916918</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mendoza-Marin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hoang</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Albores-Saavedra</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Malignant stromal tumor of the gallbladder with interstitial cells of Cajal phenotype</article-title>
          <source>Arch Pathol Lab Med</source>
          <year>2002</year>
          <volume>126</volume>
          <fpage>481</fpage>
          <lpage>483</lpage>
          <pub-id pub-id-type="pmid">11900579</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ortiz-Hidalgo</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>de Leon Bojorge</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Albores-Saavedra</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Stromal tumor of the gallbladder with phenotype of interstitial cells of Cajal: a previously unrecognized neoplasm</article-title>
          <source>Am J Surg Pathol</source>
          <year>2000</year>
          <volume>24</volume>
          <fpage>1420</fpage>
          <lpage>1423</lpage>
          <pub-id pub-id-type="pmid">11023105</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lasota</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Carlson</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Miettinen</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Spindle cell tumor of urinary bladder serosa with phenotypic and genotypic features of gastrointestinal stromal tumor</article-title>
          <source>Arch Pathol Lab Med</source>
          <year>2000</year>
          <volume>124</volume>
          <fpage>894</fpage>
          <lpage>897</lpage>
          <pub-id pub-id-type="pmid">10835530</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kindblom</surname>
              <given-names>LG</given-names>
            </name>
            <name>
              <surname>Remotti</surname>
              <given-names>HE</given-names>
            </name>
            <name>
              <surname>Aldenborg</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Meis-Kindblom</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal</article-title>
          <source>Am J Pathol</source>
          <year>1998</year>
          <volume>152</volume>
          <fpage>1259</fpage>
          <lpage>1269</lpage>
          <pub-id pub-id-type="pmid">9588894</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sircar</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hewlett</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Huizinga</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Chorneyko</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Berezin</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Riddell</surname>
              <given-names>RH</given-names>
            </name>
          </person-group>
          <article-title>Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors</article-title>
          <source>Am J Surg Pathol</source>
          <year>1999</year>
          <volume>23</volume>
          <fpage>377</fpage>
          <lpage>389</lpage>
          <pub-id pub-id-type="pmid">10199467</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Albores-Saavedra</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Henson</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Sobin</surname>
              <given-names>LH</given-names>
            </name>
          </person-group>
          <source>Histological Typing of Tumors of the Gallbladder and Extrahepatic Bile Ducts. World Health Organization</source>
          <year>1991</year>
          <publisher-loc>Berlin</publisher-loc>
          <publisher-name>Springer-Velag</publisher-name>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hjermstad</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Sobin</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>Helwig</surname>
              <given-names>EB</given-names>
            </name>
          </person-group>
          <article-title>Stromal tumors of the gastrointestinal tract: myogenic or neurogenic?</article-title>
          <source>Am J Surg Pathol</source>
          <year>1987</year>
          <volume>11</volume>
          <fpage>383</fpage>
          <lpage>386</lpage>
          <pub-id pub-id-type="pmid">3555132</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Albores-Saavedra</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Henson</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Klimstra</surname>
              <given-names>DS</given-names>
            </name>
          </person-group>
          <source>Tumors of the Gallbladder, Extrahepatic Bile Duct, and Ampulla of Vater</source>
          <year>2000</year>
          <publisher-loc>Washington, DC</publisher-loc>
          <publisher-name>Armed Forces Institute of Pathology</publisher-name>
          <comment>Atlas of Tumor Pathology, 3rd series, fascicle 27</comment>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fletcher</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Berman</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Corless</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gorstein</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Lasota</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Longley</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Miettinen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>O'Leary</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Remotti</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Rubin</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>Shmookler</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Sobin</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>Weiss</surname>
              <given-names>SW</given-names>
            </name>
          </person-group>
          <article-title>Diagnosis of gastrointestinal stromal tumors: a consensus approach</article-title>
          <source>Hum Pathol</source>
          <year>2002</year>
          <volume>33</volume>
          <fpage>459</fpage>
          <lpage>465</lpage>
          <pub-id pub-id-type="pmid">12094370</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miettinen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sarlomo-Rikala</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lasota</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Gastrointestinal stromal tumors: Recent advances in understanding of their biology</article-title>
          <source>Hum Pathol</source>
          <year>1999</year>
          <volume>30</volume>
          <fpage>1213</fpage>
          <lpage>1220</lpage>
          <pub-id pub-id-type="pmid">10534170</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heinrich</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Rubin</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>Longley</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Fletcher</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations</article-title>
          <source>Hum Pathol</source>
          <year>2002</year>
          <volume>33</volume>
          <fpage>484</fpage>
          <lpage>495</lpage>
          <pub-id pub-id-type="pmid">12094373</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Longley</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Reguera</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Classes of c-Kit activating mutations: proposed mechanisms of action and implications for disease classification and therapy</article-title>
          <source>Leuk Res</source>
          <year>2001</year>
          <volume>25</volume>
          <fpage>571</fpage>
          <lpage>576</lpage>
          <pub-id pub-id-type="pmid">11377682</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Blume-Jensen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Claesson-Welsh</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Siegbahn</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Zsebo</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Westermark</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Heldin</surname>
              <given-names>CH</given-names>
            </name>
          </person-group>
          <article-title>Activation of the human c-Kit product by ligand-induced dimerization mediates circular actin reorganization and chemotaxis</article-title>
          <source>EMBO J</source>
          <year>1991</year>
          <volume>10</volume>
          <fpage>4121</fpage>
          <lpage>4128</lpage>
          <pub-id pub-id-type="pmid">1721869</pub-id>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lux</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Rubin</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>Biase</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Maclure</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Demetri</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Xiao</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Singer</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fletcher</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Fletcher</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors</article-title>
          <source>Am J Pathol</source>
          <year>2000</year>
          <volume>156</volume>
          <fpage>791</fpage>
          <lpage>795</lpage>
          <pub-id pub-id-type="pmid">10702394</pub-id>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hirota</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Isozaki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Moriyama</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hashimoto</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nishida</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ishiguro</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kawano</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hanada</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kurata</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Takeda</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Muhammad Tunio</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Matsuzawa</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kanakura</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Shinomura</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kitamura</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors</article-title>
          <source>Science</source>
          <year>1998</year>
          <volume>279</volume>
          <fpage>577</fpage>
          <lpage>580</lpage>
          <pub-id pub-id-type="pmid">9438854</pub-id>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taniguchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nishida</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hirota</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Isozaki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nomura</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Matsuda</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kitamura</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors</article-title>
          <source>Cancer Res</source>
          <year>1999</year>
          <volume>59</volume>
          <fpage>4297</fpage>
          <lpage>4300</lpage>
          <pub-id pub-id-type="pmid">10485475</pub-id>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sakurai</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fukasawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Chong</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fukayama</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>C-kit gene abnormalities in gastrointestinal stromal tumors (tumors of interstitial cells of Cajal)</article-title>
          <source>Jpn J Cancer Res</source>
          <year>1999</year>
          <volume>90</volume>
          <fpage>1321</fpage>
          <lpage>1328</lpage>
          <pub-id pub-id-type="pmid">10665649</pub-id>
        </element-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wardelmann</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Neidt</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Bierhoff</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Speidel</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Manegold</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Fischer</surname>
              <given-names>HP</given-names>
            </name>
            <name>
              <surname>Pfeifer</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Pietsch</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant</article-title>
          <source>Mod Pathol</source>
          <year>2002</year>
          <volume>15</volume>
          <fpage>125</fpage>
          <lpage>136</lpage>
          <pub-id pub-id-type="pmid">11850541</pub-id>
        </element-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>CY</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>WW</given-names>
            </name>
            <name>
              <surname>Chin</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Jeon</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>KW</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>WB</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>SN</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>GY</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>DY</given-names>
            </name>
            <name>
              <surname>Joo</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
          <article-title>Clinical effectiveness of diagnosis using immunohistochemistry and new grade in gastrointestinal stromal tumors (GISTs)</article-title>
          <source>J Korean Surg Soc</source>
          <year>2003</year>
          <volume>64</volume>
          <fpage>471</fpage>
          <lpage>479</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" position="float">
      <label>Fig. 1</label>
      <caption>
        <p>Preoperative ultrasound reveals a significantly dilated gallbladder with wall thickening. Several high echogenic foci with low echoic debris (arrow) are present in the dependent portion of the gallbladder.</p>
      </caption>
      <graphic xlink:href="jkms-19-763-g001"/>
    </fig>
    <fig id="F2" position="float">
      <label>Fig. 2</label>
      <caption>
        <p><bold>(A)</bold> The wall of gallbladder is replaced by hypercellular spindle cells and the mucosal layer epithelium has been flattened by tumor infiltration (H&amp;E, &#xD7;40). <bold>(B)</bold> Spindle cells are interspersed with fascicle patterns (H&amp;E, &#xD7;100). <bold>(C)</bold> Higher magnification of spindle cells shows hyperchromasia and prominent nucleoli of nuclei, and mitoses are frequently noted (H&amp;E, &#xD7;400). <bold>(D)</bold> Tumor cells are stained diffusely and show moderate intensity for CD117 in the cytoplasm (Immunostain &#xD7;400).</p>
      </caption>
      <graphic xlink:href="jkms-19-763-g002"/>
    </fig>
    <fig id="F3" position="float">
      <label>Fig. 3</label>
      <caption>
        <p>Abdominal CT reveals large heterogenously enhanced low density masses with strong evidence metastasis in right hepatic lobe.</p>
      </caption>
      <graphic xlink:href="jkms-19-763-g003"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
